Sector
PharmaceuticalsOpen
₹2.86Prev. Close
₹3.01Turnover(Lac.)
₹0.21Day's High
₹3Day's Low
₹2.8652 Week's High
₹4.3352 Week's Low
₹2.5Book Value
₹0.56Face Value
₹10Mkt Cap (₹ Cr.)
5.47P/E
0EPS
0Divi. Yield
019 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
9 Sep 2024
12:00 AM
AGM
Announcement Date: 09 Sep, 2024
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 19.11 | 19.11 | 19.11 | 19.11 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -17.14 | -16.32 | -15.29 | -15.16 |
Net Worth | 1.97 | 2.79 | 3.82 | 3.95 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0 | 0 | 4.09 | 2.84 |
yoy growth (%) | -100 | -99.89 | 43.98 | 109.88 |
Raw materials | 0 | 0 | -3.52 | -8.23 |
As % of sales | 0 | 18.49 | 86.16 | 289.72 |
Employee costs | -0.4 | -0.45 | -0.65 | -0.79 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -4.49 | -1.23 | -1.05 | -7.44 |
Depreciation | -0.55 | -0.57 | -0.58 | -0.59 |
Tax paid | 0.07 | 0.06 | 0.19 | 0.05 |
Working capital | 0.77 | -1.49 | -0.12 | -10.03 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -100 | -99.89 | 43.98 | 109.88 |
Op profit growth | 512.82 | 28.2 | -92.35 | 1,295.21 |
EBIT growth | 263.47 | 17.16 | -85.82 | 567.87 |
Net profit growth | 278.49 | 34.81 | -88.28 | 520.78 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,667.15 | 93.55 | 4,00,005.13 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,991.75 | 84.03 | 1,85,608.99 | 667 | 0.43 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,491.8 | 25.03 | 1,20,493.85 | 1,485.4 | 1.07 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,354.45 | 60 | 1,13,524.73 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,269.55 | 19.69 | 1,05,954.33 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Managing Director
Peeyush Kumar Aggarwal
Company Sec. & Compli. Officer
Pooja Chuni
Independent Director
Madhu Sharma
Non Executive Director
Ram Niwas Sharma
Independent Director
Ajay Sharma
138 Roz-Ka-Meo Industrial Area,
Sohna,
Haryana - 122103
Tel: 91-124-2362471/2014471
Website: http://www.mpspharmaa.com
Email: Investor@advikindia.com, mail@advikindia.com
Beetal House 3rd Flr,
Behind Local Shp Cen, Nr Dada Harsukh Das,
New Delhi - 110062
Tel: 91-11-29961281-82
Website: www.beetalfinancial.com
Email: beetal@beetalfinancial.com
Summary
MPS Pharmaa Limited (Formerly known Advik Laboratories Limited) was incorporated in September, 1994. The Company was promoted in by the Jains along with a group of dedicated professionals. Presently, ...
Read More
Reports by MPS Pharmaa Ltd
What is the MPS Pharmaa Ltd share price today?
What is the Market Cap of MPS Pharmaa Ltd?
What is the PE and PB ratio of MPS Pharmaa Ltd?
What is the 52 Week High and Low of MPS Pharmaa Ltd?
What is the CAGR of MPS Pharmaa Ltd?
What is the shareholding pattern of MPS Pharmaa Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.